Illumina grabs GenoLogics in IT deal; Roche eyes FDA approval for cancer companion Dx;

> Illumina ($ILMN) snatched up GenoLogics Life Sciences Software to get its hands on the company's lab information management systems. Release

> Roche ($RHHBY) submitted paperwork to the FDA for premarket approval (PMA) of its companion diagnostic for AstraZeneca's ($AZN) non-small cell lung cancer drug. Statement

> Quest Diagnostics ($DGX) is teaming up with the Perinatal Quality Foundation to advance noninvasive prenatal screening in the U.S. More

> Roche Diagnostics cut the ribbon on its new Asia Pacific HQ and regional Center of Excellence in Singapore. Story

> French diagnostics company Novacyt roped in €5 million ($5.4 million) in funding to support its growth initiatives. Statement

And Finally… The U.S. Preventive Services Task Force is recommending that all women who are pregnant or are within a year of giving birth should be screened for perinatal depression. Story